An open-label, phase 2 trial of bicalutamide dose escalation from 50 mg to 150 mg in men with CAB and castration resistance. A Canadian Urology Research Consortium Study
2014
An open-label, phase 2 trial of bicalutamide dose escalation from 50 mg to 150 mg in men with CAB and castration resistance. A Canadian Urology Research Consortium Study
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
41
References
16
Citations
NaN
KQI